Hikma appoints Riad Mishlawi as CEO
Hikma Pharmaceuticals
1,798.00p
15:45 15/11/24
0.22%
4.00p
Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.
FTSE 250
20,508.75
15:45 15/11/24
n/a
n/a
FTSE 350
4,453.56
15:45 15/11/24
n/a
n/a
FTSE All-Share
4,411.85
15:45 15/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
-2.70%
-535.19
Said Darwazah will step down as acting CEO and return to his role as executive chairman.